Products for Research Use Only
RegisterLogin

CID16020046

CAT: 0498-bs-83841C-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0498-bs-83841C-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Background
CID16020046 is a selective GPR55 antagonist.1 In HEK293 cells expressing GPR55, the compound behaves as an antagonist on lysophosphatidylinositol (LPI) -mediated Ca2+ release but was inactive on cells expressing CB1 and CB2. It blocks LPI-induced migration of colon cancer cells.2 It displays protective effects against oxidized LDL-induced inflammation3, mitigates advanced glycation end products-induced chondrocyte activation4, and displays anti-inflammatory effects in various cells5,6. A useful tool for studying the role of GPR55 in cellular physiology.
Conjugation
Unconjugated
Buffer
White to off-white solid
Storage Conditions
-20°C

Alternative Products

CatalogName
S8694-25mgCID16020046
A16818-25CID16020046 25mg
A16818-5CID16020046 5mg
A16818-100CID16020046 100mg
A16818-2CID16020046 2mg
A16818-50CID16020046 50mg
A16818-10CID16020046 10mg
TBI5362-25MGCID16020046, GPR55 antagonist
A16818-10mM-DCID16020046 10mM * 1mL in DMSO
217395GPR55 Receptor Antagonist, CID16020046 (4-[4- (3-Hydroxyphenyl) -3- (4-methylphenyl) -6-oxo-1H,4H-pyrrolo[3,4-c]pyrazol-5-yl]benzoic Acid)

Popular Products